1-3 of 3
Petra Obrtlikova, MD PhD
Close
Sort by
Journal Articles

Rituximab Maintenance after Chemoimmunotherapy Induction in 1 st and 2 nd Line Improves Progression Free Survival: Planned Interim Analysis of the International Randomized AGMT-CLL8/a Mabtenance Trial

Richard Greil, MD, Petra Obrtlikova, MD PhD, Lukas Smolej, MD PhD, Tomas Kozak, MDPhD, Michael Steurer, MD, Johannes Andel, MD, Josef Thaler, MD, Eva Mikuskova, MD, Liana Gercheva, MD, Thomas Nösslinger, MD, Miriam Ladicka, MD, Michael Girschikofsky, MD, MikulᚠHrubiško, MD PhD, Prof., Ulrich Jäger, MD, Michael A. Fridrik, MD, Martin Pecherstorfer, MD, Eva Kralikova, MD, Cristina Burcoveanu, MD, Stefcho Goranov, MD, Jana Jurkovikova, MD, Andreas L. Petzer, MD, Georgi G. Mihaylov, MD PhD, Julian Raynov, MD, Horst Oexle, MD, August Zabernigg, MD, Emilia Flochova, MD PhD, Stanislav Palasthy, MD, Thomas Melchardt, MD, Jiri Mayer, MD, Alexander Egle, MD
Journal: Blood
Blood (2014) 124 (21): 20.
https://doi.org/10.1182/blood.V124.21.20.20
Published: 2014
Journal Articles

Pattern of Mir-155 and PU.1 Expression in CLL/SLL and Aggressive Lymphomas

Tomas Stopka, MD, PhD, Karin Vargova, Hana Huskova, Pavel Burda, PhD, Nikola Curik, Petra Vlckova, Vojtech Kulvait, Vit Pospisil, Filipp Savvulidi, Emanuel Necas, Marek Mraz, MD, Sarka Pospisilova, Dr, PhD, Jiri Mayer, MD, PhD, Josef Karban, Petra Obrtlikova, MD, PhD, Marek Trneny
Journal: Blood
Blood (2011) 118 (21): 4600.
https://doi.org/10.1182/blood.V118.21.4600.4600
Published: 2011
Journal Articles

Improving Survival in Patients with Chronic Lymphocytic Leukemia - Population Based Study

Marek Trneny, Petra Obrtlikova, MD, PhD, Jiri Schwarz, MD, PhD, Tomas Pavlik, Jan Muzik, MSci, PhD, Ladislav Dusek, MSci, PhD
Journal: Blood
Blood (2011) 118 (21): 2852.
https://doi.org/10.1182/blood.V118.21.2852.2852
Published: 2011